 Monika Fleshner
Concepts (699)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 59 | 2017 | 1100 | 7.420 |
Why?
| | Stress, Physiological | 47 | 2019 | 443 | 7.120 |
Why?
| | Prebiotics | 8 | 2025 | 27 | 4.840 |
Why?
| | Physical Conditioning, Animal | 22 | 2019 | 257 | 4.210 |
Why?
| | Rats, Inbred F344 | 48 | 2019 | 265 | 3.410 |
Why?
| | Rats | 137 | 2024 | 5647 | 3.380 |
Why?
| | Motor Activity | 28 | 2019 | 718 | 3.240 |
Why?
| | HSP72 Heat-Shock Proteins | 17 | 2014 | 32 | 3.150 |
Why?
| | Helplessness, Learned | 13 | 2016 | 68 | 2.950 |
Why?
| | Corticosterone | 38 | 2016 | 236 | 2.230 |
Why?
| | Running | 14 | 2016 | 230 | 2.160 |
Why?
| | Brain | 27 | 2024 | 2668 | 2.050 |
Why?
| | Rats, Sprague-Dawley | 71 | 2024 | 2486 | 1.920 |
Why?
| | Glucans | 2 | 2025 | 24 | 1.830 |
Why?
| | Oligosaccharides | 2 | 2025 | 60 | 1.780 |
Why?
| | Animals | 164 | 2025 | 36940 | 1.770 |
Why?
| | Heat-Shock Proteins | 10 | 2024 | 143 | 1.750 |
Why?
| | Gastrointestinal Microbiome | 5 | 2025 | 697 | 1.590 |
Why?
| | Electroshock | 28 | 2015 | 142 | 1.460 |
Why?
| | Cytokines | 17 | 2024 | 2085 | 1.460 |
Why?
| | Fear | 17 | 2015 | 338 | 1.450 |
Why?
| | Immune System | 9 | 2017 | 177 | 1.440 |
Why?
| | Escherichia coli Infections | 9 | 2012 | 111 | 1.390 |
Why?
| | Exosomes | 5 | 2017 | 103 | 1.370 |
Why?
| | Circadian Rhythm | 7 | 2021 | 468 | 1.360 |
Why?
| | Hemocyanins | 19 | 2008 | 62 | 1.280 |
Why?
| | Interleukin-1beta | 6 | 2016 | 372 | 1.270 |
Why?
| | Inflammation | 12 | 2024 | 2837 | 1.200 |
Why?
| | Bacteria | 7 | 2024 | 858 | 1.170 |
Why?
| | Inflammasomes | 3 | 2016 | 131 | 1.160 |
Why?
| | Exercise | 17 | 2024 | 2057 | 1.160 |
Why?
| | Immunity, Innate | 9 | 2014 | 828 | 1.140 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 185 | 1.140 |
Why?
| | Corpus Striatum | 7 | 2017 | 167 | 1.130 |
Why?
| | Physical Exertion | 6 | 2012 | 215 | 1.130 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 195 | 1.120 |
Why?
| | Spleen | 13 | 2013 | 514 | 1.090 |
Why?
| | Lactoferrin | 2 | 2018 | 31 | 1.090 |
Why?
| | Anxiety | 10 | 2018 | 1035 | 1.090 |
Why?
| | Male | 145 | 2024 | 67762 | 1.030 |
Why?
| | Immunoglobulin M | 11 | 2008 | 289 | 1.020 |
Why?
| | Feces | 4 | 2025 | 484 | 1.010 |
Why?
| | Serotonin | 10 | 2019 | 323 | 1.000 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 290 | 0.980 |
Why?
| | Diet | 5 | 2024 | 1278 | 0.980 |
Why?
| | Hypergravity | 1 | 2025 | 6 | 0.960 |
Why?
| | Interleukin-1 | 15 | 2008 | 965 | 0.950 |
Why?
| | Antibody Formation | 10 | 2008 | 298 | 0.930 |
Why?
| | Amygdala | 7 | 2017 | 191 | 0.920 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 182 | 0.900 |
Why?
| | MicroRNAs | 3 | 2017 | 692 | 0.890 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 45 | 0.860 |
Why?
| | Lipopolysaccharides | 11 | 2024 | 886 | 0.840 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 200 | 0.840 |
Why?
| | Raphe Nuclei | 7 | 2019 | 110 | 0.810 |
Why?
| | Behavior, Animal | 13 | 2019 | 501 | 0.800 |
Why?
| | Hippocampus | 18 | 2017 | 895 | 0.800 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 549 | 0.770 |
Why?
| | Conditioning, Classical | 7 | 2015 | 103 | 0.750 |
Why?
| | Adipose Tissue | 3 | 2016 | 635 | 0.740 |
Why?
| | Glycolipids | 2 | 2019 | 42 | 0.710 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 32 | 0.690 |
Why?
| | Catecholamines | 7 | 2014 | 98 | 0.680 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 847 | 0.680 |
Why?
| | Immunoglobulin G | 13 | 2008 | 893 | 0.670 |
Why?
| | Conditioning, Operant | 5 | 2012 | 100 | 0.660 |
Why?
| | Dopamine | 3 | 2015 | 303 | 0.640 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 15 | 0.640 |
Why?
| | Microbiota | 2 | 2019 | 762 | 0.640 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2607 | 0.630 |
Why?
| | Glycoproteins | 2 | 2019 | 342 | 0.630 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1242 | 0.610 |
Why?
| | Body Weight | 15 | 2016 | 985 | 0.600 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 131 | 0.590 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 301 | 0.590 |
Why?
| | Mentors | 1 | 2021 | 202 | 0.590 |
Why?
| | Sleep | 4 | 2021 | 755 | 0.580 |
Why?
| | Interleukin-10 | 7 | 2016 | 302 | 0.580 |
Why?
| | Microglia | 2 | 2021 | 251 | 0.580 |
Why?
| | Alarmins | 1 | 2017 | 26 | 0.550 |
Why?
| | Fatigue | 3 | 2012 | 329 | 0.540 |
Why?
| | Signal Transduction | 10 | 2023 | 5079 | 0.530 |
Why?
| | Food Deprivation | 1 | 2016 | 25 | 0.530 |
Why?
| | Vagus Nerve | 7 | 2000 | 86 | 0.520 |
Why?
| | Escape Reaction | 6 | 2012 | 62 | 0.520 |
Why?
| | Inflammation Mediators | 4 | 2013 | 513 | 0.520 |
Why?
| | Analysis of Variance | 15 | 2015 | 1316 | 0.500 |
Why?
| | Sleep, REM | 1 | 2016 | 33 | 0.500 |
Why?
| | Central Nervous System | 2 | 2016 | 258 | 0.490 |
Why?
| | Butyrates | 1 | 2016 | 61 | 0.490 |
Why?
| | Emotions | 3 | 2018 | 548 | 0.490 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 155 | 0.480 |
Why?
| | Association Learning | 3 | 2010 | 61 | 0.480 |
Why?
| | RNA, Messenger | 12 | 2018 | 2833 | 0.480 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 65 | 0.480 |
Why?
| | Mood Disorders | 1 | 2016 | 133 | 0.470 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 94 | 0.470 |
Why?
| | Norepinephrine | 6 | 2006 | 204 | 0.460 |
Why?
| | Chemokines | 2 | 2012 | 228 | 0.450 |
Why?
| | Interleukin-6 | 7 | 2016 | 778 | 0.450 |
Why?
| | Interleukin-18 | 2 | 2012 | 236 | 0.450 |
Why?
| | Serum | 1 | 2014 | 59 | 0.440 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1996 | 0.440 |
Why?
| | Extracellular Space | 3 | 2005 | 119 | 0.440 |
Why?
| | Sleep Deprivation | 4 | 2020 | 174 | 0.430 |
Why?
| | Time Factors | 25 | 2016 | 6828 | 0.430 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 205 | 0.430 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 33 | 0.430 |
Why?
| | Arousal | 9 | 2021 | 155 | 0.420 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 553 | 0.420 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 41 | 0.420 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 38 | 0.410 |
Why?
| | Reward | 3 | 2016 | 244 | 0.410 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 115 | 0.400 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 10 | 0.400 |
Why?
| | Transcortin | 6 | 2007 | 16 | 0.400 |
Why?
| | Glucocorticoids | 5 | 2012 | 594 | 0.390 |
Why?
| | Intestines | 1 | 2015 | 357 | 0.390 |
Why?
| | Immune Tolerance | 3 | 2005 | 363 | 0.390 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 114 | 0.380 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 390 | 0.380 |
Why?
| | Antigens | 4 | 2003 | 357 | 0.380 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 48 | 0.380 |
Why?
| | Aminopyridines | 3 | 2009 | 98 | 0.370 |
Why?
| | Nitric Oxide | 6 | 2014 | 915 | 0.360 |
Why?
| | Myeloid Cells | 1 | 2012 | 148 | 0.360 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 363 | 0.350 |
Why?
| | Mental Health | 2 | 2015 | 726 | 0.350 |
Why?
| | Body Temperature | 5 | 2014 | 222 | 0.340 |
Why?
| | Mifepristone | 3 | 2001 | 64 | 0.340 |
Why?
| | Memory | 9 | 2015 | 248 | 0.340 |
Why?
| | Limbic System | 1 | 2010 | 47 | 0.340 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 22 | 0.340 |
Why?
| | Neurons | 8 | 2017 | 1590 | 0.330 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 8 | 2014 | 852 | 0.330 |
Why?
| | Depression | 3 | 2012 | 1397 | 0.320 |
Why?
| | Metagenome | 1 | 2010 | 147 | 0.320 |
Why?
| | Volition | 1 | 2009 | 34 | 0.320 |
Why?
| | Random Allocation | 3 | 2016 | 353 | 0.320 |
Why?
| | Disease Models, Animal | 13 | 2016 | 4295 | 0.320 |
Why?
| | Extracellular Fluid | 3 | 2006 | 31 | 0.320 |
Why?
| | Brain Chemistry | 3 | 2005 | 117 | 0.320 |
Why?
| | Space Flight | 2 | 2000 | 87 | 0.310 |
Why?
| | Indoles | 3 | 2009 | 412 | 0.310 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.310 |
Why?
| | Electric Stimulation | 9 | 2013 | 264 | 0.300 |
Why?
| | Locomotion | 2 | 2012 | 106 | 0.300 |
Why?
| | Lipid Droplets | 2 | 2019 | 23 | 0.300 |
Why?
| | Up-Regulation | 4 | 2012 | 843 | 0.300 |
Why?
| | Exercise Therapy | 3 | 2008 | 443 | 0.300 |
Why?
| | Predatory Behavior | 5 | 2011 | 50 | 0.300 |
Why?
| | Fluvoxamine | 1 | 2008 | 17 | 0.290 |
Why?
| | Exercise Test | 3 | 2007 | 625 | 0.290 |
Why?
| | Antibodies | 3 | 2005 | 410 | 0.290 |
Why?
| | Homeostasis | 3 | 2017 | 621 | 0.280 |
Why?
| | B-Lymphocytes | 2 | 2003 | 847 | 0.280 |
Why?
| | Heat-Shock Response | 2 | 2024 | 77 | 0.280 |
Why?
| | Adrenal Glands | 8 | 2008 | 78 | 0.280 |
Why?
| | Mycobacterium | 2 | 2021 | 108 | 0.270 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 127 | 0.270 |
Why?
| | Humans | 46 | 2024 | 137585 | 0.270 |
Why?
| | Adrenalectomy | 11 | 2005 | 68 | 0.270 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 162 | 0.270 |
Why?
| | Extinction, Psychological | 3 | 2015 | 86 | 0.270 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 197 | 0.260 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.260 |
Why?
| | Physical Fitness | 2 | 2006 | 209 | 0.250 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 97 | 0.250 |
Why?
| | Adjuvants, Immunologic | 4 | 2003 | 226 | 0.250 |
Why?
| | Heart Rate | 6 | 2016 | 822 | 0.250 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 26 | 0.250 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 109 | 0.250 |
Why?
| | Neural Pathways | 4 | 2015 | 295 | 0.240 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 500 | 0.240 |
Why?
| | Cognition | 6 | 2024 | 1153 | 0.240 |
Why?
| | Galactose | 1 | 2025 | 33 | 0.240 |
Why?
| | Vagotomy | 8 | 2000 | 33 | 0.240 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 5 | 0.240 |
Why?
| | In Situ Hybridization | 4 | 2012 | 316 | 0.230 |
Why?
| | Immunomodulation | 2 | 2017 | 98 | 0.230 |
Why?
| | Physical Endurance | 1 | 2006 | 275 | 0.230 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 143 | 0.230 |
Why?
| | Sick Role | 1 | 2004 | 18 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 10 | 2013 | 2057 | 0.220 |
Why?
| | Persian Gulf Syndrome | 1 | 2024 | 17 | 0.220 |
Why?
| | Psychomotor Performance | 3 | 2019 | 309 | 0.220 |
Why?
| | Memory Disorders | 3 | 2013 | 164 | 0.220 |
Why?
| | Physiology | 1 | 2024 | 15 | 0.220 |
Why?
| | Immunization | 6 | 2021 | 411 | 0.220 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 198 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 162 | 0.210 |
Why?
| | Encephalitis | 1 | 2005 | 136 | 0.210 |
Why?
| | Morphine | 5 | 2011 | 158 | 0.210 |
Why?
| | CD5 Antigens | 1 | 2003 | 10 | 0.210 |
Why?
| | Social Behavior | 4 | 2016 | 287 | 0.210 |
Why?
| | CD11 Antigens | 1 | 2003 | 30 | 0.200 |
Why?
| | Hypothalamus | 4 | 2017 | 153 | 0.200 |
Why?
| | Propranolol | 3 | 2008 | 50 | 0.200 |
Why?
| | Genes, fos | 1 | 2003 | 36 | 0.200 |
Why?
| | Lung | 1 | 2016 | 4060 | 0.200 |
Why?
| | Muscle Strength | 1 | 2006 | 317 | 0.200 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 433 | 0.190 |
Why?
| | Myocardium | 4 | 2007 | 1002 | 0.190 |
Why?
| | Microdialysis | 4 | 2015 | 52 | 0.190 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 75 | 0.190 |
Why?
| | Medicine | 1 | 2024 | 121 | 0.190 |
Why?
| | Lymph Nodes | 5 | 2006 | 491 | 0.190 |
Why?
| | Depressive Disorder | 3 | 2012 | 379 | 0.190 |
Why?
| | Maze Learning | 6 | 2015 | 103 | 0.180 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 51 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2024 | 564 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 1091 | 0.180 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.180 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 46 | 0.180 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 417 | 0.180 |
Why?
| | Sex Characteristics | 2 | 2006 | 762 | 0.180 |
Why?
| | Interferon-gamma | 4 | 2001 | 789 | 0.180 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 72 | 0.180 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 7 | 0.180 |
Why?
| | Gene Expression | 2 | 2018 | 1502 | 0.180 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 596 | 0.170 |
Why?
| | Pituitary Gland | 5 | 2006 | 148 | 0.170 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 323 | 0.170 |
Why?
| | Weightlessness | 1 | 2000 | 45 | 0.170 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 312 | 0.170 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 30 | 0.170 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 32 | 0.170 |
Why?
| | Radiation Effects | 1 | 1999 | 7 | 0.160 |
Why?
| | Astronauts | 1 | 1999 | 27 | 0.160 |
Why?
| | Mental Recall | 4 | 1997 | 202 | 0.160 |
Why?
| | Dentate Gyrus | 2 | 2010 | 37 | 0.160 |
Why?
| | Exploratory Behavior | 3 | 2015 | 92 | 0.160 |
Why?
| | Avoidance Learning | 2 | 2013 | 76 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.160 |
Why?
| | Fever | 3 | 2011 | 306 | 0.160 |
Why?
| | Blood Proteins | 2 | 2002 | 252 | 0.160 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 29 | 0.160 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 53 | 0.160 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 433 | 0.160 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 60 | 0.160 |
Why?
| | Prazosin | 2 | 2011 | 23 | 0.150 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 50 | 0.150 |
Why?
| | RNA, Bacterial | 1 | 2020 | 190 | 0.150 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 6 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 4 | 2024 | 565 | 0.150 |
Why?
| | Mice | 8 | 2025 | 17787 | 0.150 |
Why?
| | Cells, Cultured | 5 | 2014 | 4193 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 532 | 0.140 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 185 | 0.140 |
Why?
| | Cats | 5 | 2015 | 210 | 0.140 |
Why?
| | Dexamethasone | 3 | 2001 | 368 | 0.140 |
Why?
| | Biomedical Research | 1 | 2024 | 692 | 0.140 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 1000 | 0.130 |
Why?
| | Peptides | 2 | 2013 | 985 | 0.130 |
Why?
| | Lymphocytes | 4 | 2011 | 397 | 0.130 |
Why?
| | Female | 22 | 2025 | 73304 | 0.130 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 7 | 0.130 |
Why?
| | Behavior | 2 | 2006 | 90 | 0.130 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 159 | 0.120 |
Why?
| | Immunoglobulins | 1 | 1996 | 171 | 0.120 |
Why?
| | Leukocyte Count | 3 | 2002 | 329 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.120 |
Why?
| | Aging | 3 | 2004 | 1864 | 0.120 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 63 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 890 | 0.120 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.120 |
Why?
| | IgG Deficiency | 1 | 1995 | 7 | 0.120 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 128 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 160 | 0.120 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 87 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 236 | 0.120 |
Why?
| | Immunity | 3 | 2002 | 143 | 0.120 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 50 | 0.120 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1724 | 0.120 |
Why?
| | Symbiosis | 1 | 2015 | 79 | 0.110 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 364 | 0.110 |
Why?
| | CD4 Antigens | 1 | 1995 | 141 | 0.110 |
Why?
| | Neuralgia | 1 | 2016 | 133 | 0.110 |
Why?
| | Enkephalins | 1 | 2014 | 20 | 0.110 |
Why?
| | Dynorphins | 1 | 2014 | 9 | 0.110 |
Why?
| | Tyrosine | 2 | 2005 | 222 | 0.110 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 10 | 0.110 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 20 | 0.110 |
Why?
| | Metabolomics | 1 | 2020 | 678 | 0.110 |
Why?
| | Hydrocortisone | 3 | 2015 | 322 | 0.110 |
Why?
| | Nitrites | 3 | 2016 | 84 | 0.110 |
Why?
| | Peritoneum | 3 | 2003 | 44 | 0.110 |
Why?
| | Culture Media | 1 | 2014 | 165 | 0.110 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 34 | 0.110 |
Why?
| | Tail | 4 | 1998 | 28 | 0.110 |
Why?
| | Convulsants | 1 | 1993 | 8 | 0.110 |
Why?
| | Primary Cell Culture | 1 | 2014 | 171 | 0.110 |
Why?
| | Anxiety Disorders | 2 | 2008 | 377 | 0.110 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 36 | 0.110 |
Why?
| | Carbolines | 1 | 1993 | 32 | 0.110 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 41 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 889 | 0.110 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 412 | 0.110 |
Why?
| | Immunity, Cellular | 3 | 2005 | 268 | 0.110 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.100 |
Why?
| | Hyperalgesia | 3 | 2016 | 123 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 73 | 0.100 |
Why?
| | Bradykinin | 1 | 2013 | 46 | 0.100 |
Why?
| | History, 21st Century | 2 | 2024 | 213 | 0.100 |
Why?
| | Molecular Probes | 1 | 2013 | 36 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 266 | 0.100 |
Why?
| | Amnesia | 2 | 2011 | 43 | 0.100 |
Why?
| | Telemetry | 1 | 2013 | 40 | 0.100 |
Why?
| | History, 20th Century | 2 | 2024 | 325 | 0.100 |
Why?
| | Diaphragm | 3 | 1998 | 42 | 0.100 |
Why?
| | Reaction Time | 3 | 2012 | 412 | 0.100 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 11 | 0.100 |
Why?
| | Cues | 3 | 2015 | 314 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1266 | 0.100 |
Why?
| | Synaptotagmin I | 1 | 2012 | 15 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2012 | 1164 | 0.100 |
Why?
| | Phenylephrine | 2 | 2001 | 75 | 0.100 |
Why?
| | Thymus Gland | 3 | 2008 | 312 | 0.100 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 81 | 0.100 |
Why?
| | Lipid Bilayers | 1 | 2013 | 98 | 0.100 |
Why?
| | Body Fat Distribution | 1 | 2012 | 49 | 0.100 |
Why?
| | Veterans | 1 | 2024 | 1476 | 0.100 |
Why?
| | Fetal Blood | 1 | 2014 | 327 | 0.100 |
Why?
| | Area Under Curve | 1 | 2013 | 314 | 0.100 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 402 | 0.100 |
Why?
| | Rats, Nude | 1 | 2012 | 26 | 0.100 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 157 | 0.100 |
Why?
| | Life Style | 2 | 2005 | 490 | 0.090 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.090 |
Why?
| | Thiazepines | 2 | 2013 | 6 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 144 | 0.090 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 21 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1077 | 0.090 |
Why?
| | Cell Communication | 1 | 2014 | 315 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 984 | 0.090 |
Why?
| | Lymphocyte Count | 2 | 2003 | 148 | 0.090 |
Why?
| | Saimiri | 1 | 2011 | 9 | 0.090 |
Why?
| | Neurobiology | 1 | 2011 | 15 | 0.090 |
Why?
| | Macrophages | 2 | 2000 | 1547 | 0.090 |
Why?
| | Uric Acid | 1 | 2012 | 163 | 0.090 |
Why?
| | Locus Coeruleus | 1 | 2011 | 23 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 46 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1120 | 0.090 |
Why?
| | Body Composition | 1 | 2015 | 684 | 0.090 |
Why?
| | Laparotomy | 1 | 2011 | 109 | 0.090 |
Why?
| | Aged | 5 | 2008 | 23961 | 0.090 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 10 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2012 | 129 | 0.090 |
Why?
| | Endocrine Glands | 1 | 1990 | 15 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 259 | 0.090 |
Why?
| | C-Reactive Protein | 3 | 2024 | 410 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 346 | 0.080 |
Why?
| | Epinephrine | 3 | 2004 | 139 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 515 | 0.080 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 362 | 0.080 |
Why?
| | Interleukin-2 | 1 | 1992 | 455 | 0.080 |
Why?
| | Microinjections | 2 | 2008 | 86 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 273 | 0.080 |
Why?
| | Liver | 4 | 2006 | 1943 | 0.080 |
Why?
| | Pain | 4 | 2011 | 756 | 0.080 |
Why?
| | Cell Count | 2 | 2002 | 324 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 22 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1738 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 455 | 0.080 |
Why?
| | Glucose | 1 | 2014 | 1020 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 52 | 0.080 |
Why?
| | Naltrexone | 4 | 1994 | 97 | 0.080 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 69 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 494 | 0.080 |
Why?
| | Neutrophils | 3 | 2011 | 1238 | 0.070 |
Why?
| | Reference Values | 5 | 2007 | 816 | 0.070 |
Why?
| | Analgesics | 1 | 1990 | 206 | 0.070 |
Why?
| | Nadolol | 1 | 2008 | 4 | 0.070 |
Why?
| | Insulin | 2 | 2016 | 2409 | 0.070 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 55 | 0.070 |
Why?
| | Escherichia coli | 2 | 2002 | 815 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 327 | 0.070 |
Why?
| | Flow Cytometry | 2 | 2003 | 1178 | 0.070 |
Why?
| | Lipids | 1 | 2012 | 672 | 0.070 |
Why?
| | Isoproterenol | 1 | 2008 | 113 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 55 | 0.070 |
Why?
| | Pyrazines | 1 | 2008 | 90 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 31 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 57 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 256 | 0.070 |
Why?
| | Weight Loss | 1 | 1993 | 787 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 134 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 202 | 0.070 |
Why?
| | Mesentery | 2 | 1998 | 48 | 0.070 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 16 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 644 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 45 | 0.060 |
Why?
| | Blood Glucose | 1 | 2016 | 2186 | 0.060 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1353 | 0.060 |
Why?
| | Fluoxetine | 1 | 2006 | 54 | 0.060 |
Why?
| | Estrous Cycle | 1 | 2006 | 20 | 0.060 |
Why?
| | Piperazines | 1 | 2008 | 350 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 655 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 181 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 108 | 0.060 |
Why?
| | Labetalol | 1 | 2005 | 6 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2691 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 3 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 5 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 15 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 1 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 133 | 0.060 |
Why?
| | Postural Balance | 1 | 2008 | 215 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 89 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1996 | 123 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1759 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 61 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 60 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.060 |
Why?
| | RNA | 1 | 2011 | 921 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 75 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1910 | 0.060 |
Why?
| | Progesterone | 1 | 2006 | 254 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 29 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 60 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 189 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 657 | 0.050 |
Why?
| | Physical Education and Training | 1 | 2024 | 76 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 203 | 0.050 |
Why?
| | Concanavalin A | 1 | 2003 | 76 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1142 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 240 | 0.050 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 17 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2005 | 236 | 0.050 |
Why?
| | Adult | 10 | 2024 | 37929 | 0.050 |
Why?
| | Hypertension | 1 | 2013 | 1295 | 0.050 |
Why?
| | Blood Pressure | 4 | 2015 | 1786 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 7 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2004 | 149 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 405 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 34 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 311 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 385 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 367 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 94 | 0.050 |
Why?
| | Biology | 1 | 2024 | 88 | 0.050 |
Why?
| | Colony-Forming Units Assay | 1 | 2002 | 91 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 138 | 0.050 |
Why?
| | Dermatitis | 1 | 2002 | 20 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 365 | 0.050 |
Why?
| | Biomarkers | 3 | 2015 | 4149 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 353 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 1992 | 1238 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 524 | 0.050 |
Why?
| | Naloxone | 3 | 2012 | 122 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 389 | 0.050 |
Why?
| | Hot Temperature | 2 | 2021 | 391 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 332 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 738 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2024 | 195 | 0.050 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.050 |
Why?
| | Acute Disease | 2 | 2002 | 1007 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2004 | 353 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 794 | 0.050 |
Why?
| | Reflex, Startle | 2 | 2015 | 65 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10388 | 0.050 |
Why?
| | Middle Aged | 4 | 2024 | 33479 | 0.050 |
Why?
| | Universities | 1 | 2024 | 433 | 0.050 |
Why?
| | Epitopes | 1 | 2003 | 479 | 0.050 |
Why?
| | Learning | 3 | 2008 | 409 | 0.040 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 34 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 1998 | 206 | 0.040 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 24 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2001 | 34 | 0.040 |
Why?
| | Neurons, Afferent | 2 | 1998 | 97 | 0.040 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 28 | 0.040 |
Why?
| | Spironolactone | 1 | 2001 | 36 | 0.040 |
Why?
| | Health Status | 1 | 2006 | 792 | 0.040 |
Why?
| | Skin | 2 | 2002 | 752 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 4 | 0.040 |
Why?
| | Complement Activation | 1 | 2003 | 415 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 10 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 343 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 22 | 0.040 |
Why?
| | Cells | 1 | 1999 | 25 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3196 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 50 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 141 | 0.040 |
Why?
| | Obesity | 1 | 1993 | 2992 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 217 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1793 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 72 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 62 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 92 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 700 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 730 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 5 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 220 | 0.040 |
Why?
| | Eating | 3 | 2000 | 380 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 32 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 345 | 0.040 |
Why?
| | United States | 1 | 2016 | 14841 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 253 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 423 | 0.040 |
Why?
| | Administration, Oral | 1 | 2001 | 816 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 102 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 125 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2139 | 0.040 |
Why?
| | Polysomnography | 1 | 2019 | 185 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 15657 | 0.040 |
Why?
| | Bacteriophages | 1 | 1999 | 98 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 183 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 400 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 269 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.040 |
Why?
| | Individuality | 1 | 2019 | 156 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2900 | 0.030 |
Why?
| | Antigens, CD | 1 | 2000 | 521 | 0.030 |
Why?
| | Oxytocics | 1 | 1997 | 15 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1570 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 327 | 0.030 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 275 | 0.030 |
Why?
| | Altitude | 1 | 2001 | 488 | 0.030 |
Why?
| | Anesthesia | 2 | 1990 | 189 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 5 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 191 | 0.030 |
Why?
| | Weight Gain | 1 | 2000 | 519 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 16 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 15 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 29 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1226 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 77 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 48 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3715 | 0.030 |
Why?
| | Attention | 1 | 2019 | 427 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 216 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 60 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1999 | 341 | 0.030 |
Why?
| | Azides | 1 | 1996 | 46 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 289 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 173 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 133 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 245 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 223 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 283 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 69 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 151 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 594 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 370 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 218 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 43 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 18 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 27 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 382 | 0.030 |
Why?
| | Neck | 1 | 1995 | 101 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1272 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 201 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 451 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4565 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 150 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 410 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 558 | 0.030 |
Why?
| | Memory, Short-Term | 2 | 2008 | 250 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 385 | 0.030 |
Why?
| | Clonidine | 1 | 2013 | 28 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 22 | 0.030 |
Why?
| | Static Electricity | 1 | 2013 | 118 | 0.030 |
Why?
| | Neural Inhibition | 1 | 1994 | 169 | 0.030 |
Why?
| | Amitriptyline | 1 | 2013 | 21 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2013 | 91 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 5778 | 0.030 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.030 |
Why?
| | Neurogenesis | 1 | 2014 | 149 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Fasting | 1 | 2014 | 281 | 0.020 |
Why?
| | Drug Administration Routes | 1 | 2012 | 38 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 168 | 0.020 |
Why?
| | Anthropometry | 1 | 1993 | 213 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 149 | 0.020 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 2 | 0.020 |
Why?
| | Adolescent Health Services | 1 | 1993 | 71 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 86 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 74 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 72 | 0.020 |
Why?
| | Self Administration | 1 | 2012 | 123 | 0.020 |
Why?
| | Hand Strength | 2 | 2004 | 123 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 192 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 99 | 0.020 |
Why?
| | Sex Factors | 2 | 2008 | 2071 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 185 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 159 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 849 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 257 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 173 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 10811 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 321 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 44 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 16 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 223 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 181 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 264 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 43 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 21513 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 64 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 3457 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 8 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 173 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 26 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 955 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 97 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 32 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 7635 | 0.020 |
Why?
| | Noise | 1 | 2010 | 65 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 42 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 32 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 188 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 898 | 0.020 |
Why?
| | Posture | 1 | 1989 | 185 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 477 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 129 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 57 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 844 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 184 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2167 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 139 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 481 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 77 | 0.020 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 20 | 0.020 |
Why?
| | Action Potentials | 3 | 1999 | 493 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 2224 | 0.020 |
Why?
| | Cell Line | 1 | 1992 | 2847 | 0.020 |
Why?
| | Sodium Channels | 1 | 2006 | 65 | 0.020 |
Why?
| | Models, Animal | 1 | 2007 | 384 | 0.020 |
Why?
| | Epithelium | 1 | 2006 | 313 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 24 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.010 |
Why?
| | Autoimmunity | 1 | 1991 | 908 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 24 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 36 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 260 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 28 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 105 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1092 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 105 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 82 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 9 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 143 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 296 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 179 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 67 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 171 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 198 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 810 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 297 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 188 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 400 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 28 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 28 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 33 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 424 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 12 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 352 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 103 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 133 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 87 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 200 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 199 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 70 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 164 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 409 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 922 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 221 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 77 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 224 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5131 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 696 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 45 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 125 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 13209 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 6 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 433 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 3 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 9 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 5 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 18 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 40 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 65 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2671 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3556 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 80 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 3 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 30 | 0.010 |
Why?
| | Child | 1 | 1993 | 21935 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1303 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 31 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 179 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 1024 | 0.010 |
Why?
| | Mitochondria | 1 | 1996 | 948 | 0.000 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 2 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|